Single versus multiple drug focus in substance abuse clinical trials research

Drug and Alcohol Dependence

Volumn 70, Issue 2, 2003, Pages 117-125

  Rounsaville, Bruce J ^a,b   Petry, Nancy M ^c   Carroll, Kathleen M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Clinical trials; Methodology; Pharmacotherapy; Polysubstance abuse; Technology transfer; Treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DIAMORPHINE; DISULFIRAM; ILLICIT DRUG; METHADONE; MONOAMINE OXIDASE INHIBITOR; NALTREXONE; NICOTINE; OPIATE ANTAGONIST; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ALCOHOLISM; BEHAVIOR THERAPY; CLINICAL TRIAL; COCAINE DEPENDENCE; DRUG CONTRAINDICATION; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; HUMAN; NAUSEA; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW; SMOKING; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT PLANNING; WITHDRAWAL SYNDROME;

EID: 0042130542     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00033-4     Document Type: Review

References (65)

1. Alterman A.I., McDermott P.A., Cook T.G., Cacciola J.S., McKay J.R., McLellan A.T., Rutherford M.J. Generalizability of the clinical dimensions of the Addiction Severity Index to nonopioid-dependent patients. Psychol. Addict. Behav. 14:(3):2000;287-294.
2. Anton R.F., Drobes D.J. Clinical measurement of craving in addiction. Psychiatr. Ann. 28:(10):1998;553-560.
3. Babor T.F., Longabaugh R., Zweben A., Fuller R.K., et al. Issues in the definition and measurement of drinking outcomes in alcoholism treatment research. J. Stud. Alcohol Suppl. 12:1994;101-111.
4. Babor T.F., Steinberg K., Anton R., Del-Boca F. Talk is cheap: measuring drinking outcomes in clinical trials. J. Stud. Alcohol. 61:(1):2000;55-63.
5. Ball J.C., Ross A. The effectiveness of methadone maintenance treatment. 1991;Springer-Verlag, New York.
6. Bryk A.S., Raudenbush S.W. Application of hierarchical linear models to assessing change. Psychol. Bull. 101:1987;147-158.
7. Budney A.J., Higgins S.T., Hughes J.R., Bickel W.K. Nicotine and caffeine use in cocaine-dependent individuals. J. Subst. Abuse. 5:(2):1993;117-130.
8. Burling T.A., Ziff D.C. Tobacco smoking: a comparison between alcohol and drug abuse inpatients. Addict. Behav. 13:(2):1988;185-190.
9. Caetano R., Weisner C. The association between DSM-III-R alcohol dependence, psychological distress and drug use. Addiction. 90:1995;351-359.
10. Carroll K.M. Methodological issues and problems in the assessment of substance use. Psychol. Assess. 7:(3):1995;349-358.
11. Carroll K.M. Relapse prevention as a psychosocial treatment: a review of controlled clinical trials. Exp. Clin. Psychopharmacol. 4:(1):1996;46-54.
12. Carroll K.M. Combined treatments for substance dependence. Sammons M.T., Schmidt N.B. Combined Treatments for Mental Disorders: a Guide to Psychological and Pharmacological Interventions. Pharmacological and Psychotherapeutic Strategies for Intervention. 2001;215-238 APA Press, Washington, DC.
13. Carroll K.M., Rounsaville B.J., Bryant K.J. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J. Stud. Alcohol. 54:(2):1993;199-208.
14. Carroll K.M., Nich C., Ball S.A., McCance E., Frankforter T.L., Rounsaville B.J. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction. 95:(9):2000;1335-1349.
15. Chick J., Gough K., Falkowski W., Kershaw P., Hore B., Mehta B., Ritson B., Ropner R., Torley D. Disulfiram treatment of alcoholism. Br. J. Psychiatry. 161:1992;84-89.
16. Ciraulo D.A., Sands B.F., Shader R.I. Critical review of liability for benzodiazepine abuse among alcoholics. Am. J. Psychiatry. 145:1988;1501-1506.
17. Cisler R.A., Zweben A. Development of a composite measure for assessing alcohol treatment outcome: operationalization and validation. Alcohol. Clin. Exp. Res. 23:1999;263-271.
18. Crits-Christoph P., Siqueland L., Blaine J., Frank A., Luborsky L., Onken L.S., Muenz L.R., Thase M.E., Weiss R.D., Gastfriend D.R., Woody G.E., Barber J.P., Butler S.F., Daley D., Salloum I., Bishop S., Najavits L.M., Lis J., Mercer D., Griffin M.L., Moras K., Beck A.T. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch. Gen. Psychiatry. 56:(6):1999;493-502.
19. Cunningham J.A., Sobell L.C., Gavin D.R., Sobell M.B., Breslin F.C. Assessing motivation for change: preliminary development and evaluation of a scale measuring the costs and benefits of changing alcohol or drug use. Psychol. Addict. Behav. 11:(2):1997;107-114.
20. Cunningham-Williams R.M., Cottler L.B., Compton W.M., Spitznagel E.L., Ben-Abdallah A. Problem gambling and comorbid psychiatric and substance use disorders among drug users recruited from drug treatment and community settings. J. Gambling Stud. 16:(4):2000;347-376.
21. Dahlke F., Lohaus A., Gutzmann H. Reliability and clinical concepts underlying global judgements in dementia: implications for clinical research. Psychopharmacol. Bull. 28:1992;425-432.
22. DelBoca F.K., Noll J.A. Truth or consequences: the validity of self-report data in health services research on addictions. Addiction. 95:(3):2000;S347-S360.
23. Dunn C., Deroo L., Rivara F.P. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 96:(12):2001;1725-1742.
24. Endicott J., Spitzer R.L., Fleiss J.L., et al. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry. 33:1976;766-771.
25. Fuller R.K., Branchey L., Brightwell D.R., Derman R.M., Emrick C.D., Iber F.L., James K.E., Lacoursiere R.B., Lee K.K., Lowenstam I. Disulfiram treatment for alcoholism: a Veterans Administration cooperative study. J. Am. Med. Assoc. 256:1986;1449-1455.
26. Galen L.W., Henderson M.J. Validation of cocaine and marijuana effect expectancies in a treatment setting. Addict. Behav. 24:(5):1999;719-724.
27. George T.P., Chawarski M.C., Pakes J., Carroll K.M., Kosten T.R., Schottenfeld R.S. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol. Psychiatry. 47:(12):2000;1080-1086.
28. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 90:(5):1995;607-614.
29. Gossop M., Best D., Marsden J., Strang J. Test-retest reliability of the Severity of Dependence Scale. Addiction. 92:(3):1997;353.
30. Greenstein R.A., Fudala P.J., O'Brien C.P. Alternative pharmacotherapies for opiate addiction. Lowinsohn J.H., Ruiz P., Millman R.B., Langrod J.G. Comprehensive Textbook of Substance Abuse. 3rd ed. 1997;415-425 Williams and Wilkins, New York.
31. Helzer J.E., Pryzbeck T.R. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol. 49:1988;219-224.
32. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E. Alcohol dependence and simultaneous cocaine and alcohol use in cocaine-dependent patients. J. Addict. Dis. 13:1994;177-189.
33. Hohmann A.A., Shear M.K. Community-based intervention research: coping with the 'noise' of real life in study design. Am. J. Psychiatry. 159:(2):2002;201-207.
34. Hubbard R.L. Treating combined alcohol and drug abuse in community-based programs. Galanter M. Recent Developments in Alcoholism. 1990;273-283 Plenum, New York.
35. Hughes J.R., Rose G.L., Callas P.W. Nicotine is more reinforcing in smokers with a past history of alcoholism than in smokers without this history. Alcohol. Clin. Exp. Res. 24:(11):2000;1633-1638.
36. Institute of Medicine, 1998. Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment. National Academy Press, Washington, DC.
37. Krishnan-Sarin S., Rosen M.I., O'Malley S.S. Naloxone challenge in smokers. Preliminary evidence of a common opioid component in nicotine dependence. Arch. Gen. Psychiatry. 56:1999;663-668.
38. Lin X., Ryan L., Sammel M., Zhang D., Padungtod C., Xu X. A scaled linear mixed model for multiple outcomes. Biometrics. 56:2000;593-601.
39. Lu N.T., Taylor B.G., Riley K.J. The validity of adult arrestee self-reports of crack cocaine use. Am. J. Drug Alcohol Abuse. 27:(3):2001;399-419.
40. Martin C.S., Clifford P.R., Maisto S.A., Earleywine M., Kirisci L., Longabaugh R. Polydrug use in an inpatient treatment sample of problem drinkers. Alcohol. Clin. Exp. Res. 20:1996;413-417.
41. McConnaughy E.A., Prochaska J.O., Velicer W.F. Stages of change in psychotherapy: measurement and sample profiles. Psychother. Theory Res. Pract. 20:(3):1983;368-375.
42. McLellan A.T., Luborsky L., Cacciola J., Griffith J., et al. New data from the addiction severity index. Reliability and validity in three centers. J. Nerv. Mental Dis. 173:(7):1985;412-423.
43. McLellan A.T., Alterman A.I., Metzger D.S., Grissom G.R., Woody G.E., Luborsky L., O'Brien C.P. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services. J. Consult. Clin. Psychol. 62:(6):1994;1141-1158.
44. Miele G.M., Carpenter K.M., Cockerham M.S., Trautman K.D., Blaine J., Hasin D.S. Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS). Drug Alcohol Depend. 59:(1):2000;77-88.
45. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch. Gen. Psychiatry. 49:1992;894-898.
46. Petrakis I.L., Carroll K.M., Nich C., Gordon L.T., McCance-Katz E.F., Frankforter T., Rounsaville B.J. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction. 95:(2):2000;219-228.
47. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes and they will come: contingency management for the treatment of alcohol dependence. J. Consult. Clin. Psychol. 68:2000;250-257.
48. Pocock S.J. Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation. Control. Clin. Trials. 18:1997;530-545.
49. Project Match Research Group, 1997. Matching alcoholism treatments to client heterogeneity: project MATCH post-treatment drinking outcomes. J. Stud. Alcohol 58, 7-29.
50. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. J. Am. Med. Assoc. 264:(19):1990;1511-1518.
51. Rohsenow D.J., Monti P.M., Martin R.A., Michalec E., Abrams D.B. Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J. Consult. Clin. Psychol. 68:(3):2000;515-520.
52. Ross H.E. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction. 88:1993;209-218.
53. Rounsaville B.J., Carroll K.M., Onken L.S. A stage model of behavioral therapies research: getting started and moving on from stage I. Clin. Psychol. Sci. Pract. 8:(2):2001;133-142.
54. Sammel M., Lin X., Ryan L. Multivariate linear mixed models for multiple outcomes. Stat. Med. 18:1999;2479-2492.
55. Sanchez C.M., Wilkinson D.A., Davila R. Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers. Am. J. Public Health. 85:(6):1995;823-828.
56. Schmitz J., Dejong J., Garnett D., Moore V., Waxman R., Linnoila M., Roy A., Lamparski D. Substance abuse among subjects seeking treatment for alcoholism. Arch. Gen. Psychiatry. 48:1991;182-183.
57. Schouten H.J.A. Combined evidence from multiple outcomes in a clinical trial. J. Clin. Epidemiol. 53:2000;1137-1144.
58. Schwartz R.H. Urine testing in the detection of drugs of abuse. Achiv. Intern. Med. 148:1988;2407-2412.
59. Sobell L.C., Sobell M.B. Timeline Follow-Back: a technique for assessing self-reported alcohol consumption. Litten R., Allen J. Measuring Alcohol Consumption. 1992;41-71 Humana Press, New Jersey.
60. Solomon K.E., Annis H.M. Development of a scale to measure outcome expectancy in alcoholics. Cognit. Ther. Res. 13:(5):1989;409-421.
61. Stout R.L., Wirtz P.W., Carbonari J.P., Del Boca F.K. Ensuring balanced distribution of prognostic factors in treatment outcome research. J. Stud. Alcohol. 12:1994;70-75.
62. Tsuang J.W., Shapiro E., Smith T.L., Schuckit M.A. Drug use among primary alcoholic veterans. Am. J. Drug Alcohol Abuse. 20:1994;483-493.
63. Volpicelli J.R., Alterman A.I., Hayashida M., et al. Naltrexone and the treatment of alcohol dependence. Arch. Gen. Psychiatry. 49:1992;876-880.
64. Warner E.A., Kosten T.R., O'Connor P.G. Pharmacotherapy for opioid and cocaine abuse. Med. Clin. North Am. 81:(4):1997;909-925.
65. Wei L.J. An application of an urn model to the design of sequential controlled clinical trials. J. Am. Stat. Assoc. 73:1978;559-563.